On June 1, Janet B. McGill, MD, MA, FACP, Maamoun Salam, MD and colleagues has their work titled “Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use among Older Adults with Type 1 Diabetes,” published in “Diabetes Technology and Therapeutics.”
In the study, they evaluate the Wireless Innovation for Seniors with Diabetes Mellitus randomized clinical trial to assess glycemic outcomes. The 26-week clinical trial compared continuous glucose monitoring (CGM) with blood glucose monitoring in 203 adults who were 60 years old with type 1 diabetes.
In evaluation of the results, they concluded that “CGM use reduced hypoglycemia without increasing hyperglycemia in older adults with type 1 diabetes. This data provides further evidence for fully integrating CGM into clinical practice.”